Protective CD8+ T Cell Responses against the Pre-erythrocytic Stages of Malaria Parasites: An Overview

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 2, 2001, Pages 221-227

  Oliveira Ferreira, J ^a   Daniel Ribeiro, C T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

CD8+ and CD4+ epitopes; CTL and helper peptides; Cytotoxic T lymphocyte (CTL) responses; Malaria; Recombinant vectors; Ty virus like particles (VLP)

Indexed keywords

ANIMALIA; ANKARA; PLASMODIUM BERGHEI; VACCINIA; VACCINIA VIRUS;

MALARIA VACCINE;

ANIMAL; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; ERYTHROCYTE; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; MOUSE; PARASITOLOGY; PLASMID; PLASMODIUM; REVIEW;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; ERYTHROCYTES; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MICE; PLASMIDS; PLASMODIUM; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035259141     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000200014     Document Type: Article

References (56)

1. Adams SE, Dawson KM, Gull K, Kingsman SM, Kingsman AJ 1987. The expression of hybrid HIV:Ty virus like particles in yeast. Nature 329: 68-70.
2. + cytotoxic T cells. J Exp Medicine 172: 1083-1090.
3. Allsopp CEM, Plebanski M, Gilbert S, Sinden RE, Harris S, Frankel G, Dougan G, Hioe C, Nixon D, Paoletti E, Layton G, Hill AVS 1996. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur J Immunol 26: 1951-1959.
4. Chen DH, Tigelaar RE, Weinbaum FI 1977. Immunity to sporozoite-induced malaria infection in mice. I the effect of immunization of T and B cell deficient mice. J Immunol 118: 1322-1327.
5. Clyde DF, Most H, McCarthy VC, Vanderberg JP 1973. Immunization of man against sporozoite-induced falciparum malaria. Am J Med Science 266: 169-177.
6. Deres K, Schild H, Weismuller KH, Jung G, Rammensee HG 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptides vaccine. Nature 342: 561-563
7. Doolan DL, Hedstrom RC, Rogers W, Charoenvit Y, Rogers W, de la Vega M, Hoffman SL 1996a. Identification and characterization of the protective hepatocyte erythrocyte protein 17kDa gene of Plasmodium yoelii, homologous of Plasmodium falciparum exported protein 1. J Biol Chem 271: 17861-17868.
8. Doolan DL, Khanboonruang C, Beck HP, Houghten RA, Good MF 1993. Cytotoxic lymphocyte T cell low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally exposed endemic population: analysis of human CTL response to most known variants. Int Immunol 5: 37-46.
9. + T cell, interferon-γ and nitric oxide dependent immunity. J Exp Med 183: 1739-1746.
10. Flynn JL, Weiss WR, Norris KA, Seifer HS, Kumar S, So M 1990. Generation of cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol Microbiol 4: 2111-2118.
11. Franke ED, Corradin G, Hoffman SL 1997. Induction of protective CTL response against the Plasmodium yoelii circumsporozoite protein immunization with peptides. J Immunol 159: 3424-3433.
12. Gonzalez C, Hone D, Noriega FR, Tacket CO, Davis JR, Losonsky G, Nataro JP, Hoffman S, Malik A, Nardin E, Sztein MB, Heppner DG, Fouts TR, Isibasi A, Levine MM 1994. Salmonella typhimurium vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction safety and immunogenicity in humans. J Infec Dis 169: 927-931.
13. Griffiths JC, Berrie EL, Holdsworth L, Moore JP, Harris SJ, Senior JM, Kingsman AJ, Adams SE 1991. Induction of high-liter neutralizing antibodies, using hybrid human immunodeficient virus V-3:Ty virus like particles in a clinically relevant adjuvant. J Virol 65: 450-456.
14. Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikut Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G 1987. A liver-stage antigen of Plasmodium falciparum characterized by gene cloning. Nature (London) 360: 434-439.
15. Harris SE, Gearing AJH, Layton GT, Adams SE, Kingsman SM, Kingsman AJ 1993. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles. Immunology 77: 135-321.
16. Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL 1991. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252: 715-718.
17. Kingsman SM, Kingsman AJ 1988. Polyvalent recombinant antigens: a new vaccine strategy. Vaccine 6: 304.
18. Klotz FW, Scheller LF, Seguin MC, Kumar N, Marietta MA, Green SJ, Azad AF 1995. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J Immunol 154: 3391-3395.
19. Kumar S, Miller L, Quakyi I, Houghten R, Maloy W, Moss B, Berzofsky J, Good M 1988. Cytotoxic T cells specific for the circumsporozoites protein of Plasmodium falciparum. Nature 334: 258-160.
20. Layton GT, Harris SJ, Gearing AJH, Hill-Perkins M, Cole JS, Griffiths JC, Burns NR, Kingsman AJ, Adams SE 1993. Induction of HIV-specific cytotoxic T lymphocytes are primed in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J Immunol 151: 1097-1107.
21. + T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA 90: 5214.-5218
22. Li S, Schulman JL, Moran T, Bona C, Palese P 1992. Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol 66:399-404.
23. Mallik A, Egan JE, Houghten R, Sadoff JC, Hoffman SL 1991. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA 88: 3300-3304.
24. Migliorini P, Betschart B, Corradin G 1993. Malaria vaccine: immunization of mice with synthetic T cell helper alone leads to protective immunity. Eur J Immunol 23: 582-584.
25. Mor G, Singla M, Steinberg A, Hoffman S, Okuda L, Klinman D 1997. Do DNA vaccines induce autoimmunity disease? Hum Gene Ther 8: 293-300.
26. + T cell responses induced by recombinant influenza and vaccinia viruses. Cel Immunol 173: 96-107.
27. Nussenzweig RS, Vanderberg J, Most H, Orton C 1967. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216: 160-162.
28. Nussenzweig RS, Vanderberg J, Most H, Orton C 1970. Immunity in simian malaria induced by irradiated sporozoites . J Parasitol 56: 252-257.
29. Nussler AK, Renia L, Pasquetto V, Miltgen F, Matile H, Mazier D 1993. In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated sporozoites, malaria blood parasites or adjuvants. Eur J Immunol 23: 882-887.
30. Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR 1998. Phase I / IIa safety, immunogenicity and efficacy trial of NYVAC-Pf7, a pox-vectored multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis 177: 1664-1673.
31. + T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus. Vaccine 18: 1863-1869.
32. Plebanski M, Gilbert SC, Schneider J, Hannan CM, Layton G, Blanchard T, Becker M, Smith G, Butcher G, Sinden RE, Hill A 1998. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I restricted epitope with recombinant carriers suitable for human use. Eur J Immunol 28: 4345-4355.
33. + T cell clones against Plasmodium voelii liver stages. J Immunol 150: 1471-1478.
34. + T lymphocytes from mice immunized with synthetic malaria peptides. Proc Natl Acad Sci USA 88: 7963-7967.
35. + cytolitic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3: 579-585.
36. + T cell and B cell epitopes. J Immunol 153: 4636-4648.
37. + T cell-mediated protective immunity against malaria. J Immunol 158: 1268-1274.
38. Rogers WO, Malik A, Melouk S, Nakamura K, Rogers MD, Szarfman A, Gordon MD, Nussler AK, Aikawa M, Hoffman SL 1992. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA 89: 579-585.
39. Romero P, Eberl G, Casanova JL, Cordey AS, Widmann C, Luescher I, Corradin G, Maryanski J 1992. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. J Immunol 143: 4263-4266.
40. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F 1989. Cloned cytotoxic T cells recognized an epitope in the circumsporozoite protein protect against malaria. Nature 341: 323-325.
41. Sadoff J, Ballou W, Baron L, Majarian W, Brey R, Hockmeyer W, Cryz S, Ou J, Lowell G, Chulay J 1988. Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240: 336-338.
42. Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, Hannan CM, Backer M, Siden R, Smith GL, Hill AVS 1998. Enhanced immunogenicity for CTL induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med 4: 397-402.
43. + cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666.
44. Sedegah M, Hedstrom RC, Hobart P, Hoffman SL 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 88: 2726-2730.
45. + cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. J Immunol 149: 966-971.
46. + T cells. J Exp Med 180: 353-358.
47. Tine JA, Lanar DE, Smith DM, Wellde BT, Schultheiss P, Ware LA, Kauffman EB, Wirtz RA, De Taisne C, Hui GS, Chang SP, Church P, Hollingdale MR, Kaslow DC, Hoffman S, Guito KP, Ballou WR, Sadoff JC, Paoletti E 1996. NYVAC-pH: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infec Immun 64: 3833-3844.
48. Tsuji M, Romero PJ, Nussenzweig RS, Zavala F 1990. CD4+ cytolitic T cell clone confers protection against murine malaria. J Exp Med 172: 1353-1358.
49. Valmori D, Romero JF, Men Y, Maryanki JL, Romero P, Corradin G 1994. Induction of a cytotoxic T cell response by coinjection of a helper peptide and cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. J Immunol 24: 1458-1462.
50. Vandenberg J, Nussenzweig RS, Most H 1969. Protective immunity produced by injection of x-irradiated sporozoite of P. berghei. V. In vitro effects of immune serum on sporozoites. Mil Med 134: 1183-1187.
51. + T cell and IFN-gamma-dependent elimination of infected hepatocytes. J Immunol 157: 4061-4067.
52. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, Weiss WR, Sedegah M, Taisne C, Norman JA, Hoffman SL 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by malaria DNA vaccine. Science 282: 476-480.
53. Weiss WR, Mellouk S, Houghten R, Sedegah M, Kumar S, Good MF, Berzofsky JA, Miller LH, Hoffman SL 1990. Cytotoxic T cells recongnize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 171: 763-773.
54. + T cells (cytotoxic/suppressor) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 85: 573-576.
55. WHO-World Health Organization 1997. World malaria situation in 1994. Weekly Epidemiol Rec 72: 269-274.
56. Widmann C, Romero P, Maryanski JL, Corradin G, Valmori D 1992. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J Immunol Meth 155: 95-99.